PL1809273T3 - Zastosowanie (di)karbaminianów 2-fenylo-1,2-etanodiolu do leczenia rozwoju padaczki - Google Patents

Zastosowanie (di)karbaminianów 2-fenylo-1,2-etanodiolu do leczenia rozwoju padaczki

Info

Publication number: PL1809273T3
Authority: PL; Poland
Prior art keywords: ethanediol; carbamates; phenyl; treating epileptogenesis; epileptogenesis
Prior art date: 2004-09-16

Application number

PL05810288T

Other languages

English (en)

Inventor

Yong Moon Choi

Robert Gordon

Gerald P Novak

Carlos R Plata-Salaman

Roy E Twyman

H Steve White

Boyu Zhao

Original Assignee

Janssen Pharmaceutica Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-09-16

Filing date

2005-09-15

Publication date

2010-09-30

2005-09-15 Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv

2005-09-15 Priority claimed from PCT/US2005/032861 external-priority patent/WO2006033947A2/en

2010-09-30 Publication of PL1809273T3 publication Critical patent/PL1809273T3/pl

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Emergency Medicine (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

PL05810288T 2004-09-16 2005-09-15 Zastosowanie (di)karbaminianów 2-fenylo-1,2-etanodiolu do leczenia rozwoju padaczki PL1809273T3 (pl)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
US61027604P	2004-09-16	2004-09-16
US69862505P	2005-07-12	2005-07-12
US70724205P	2005-08-11	2005-08-11
PCT/US2005/032861 WO2006033947A2 (en)	2004-09-16	2005-09-15	Use of 2-phenyl-1, 2-ethanediol- (di) carbamates for treating epileptogenesis and epilepsy
EP05810288A EP1809273B1 (en)	2004-09-16	2005-09-15	Use of 2-phenyl-1,2-ethanediol-(di)carbamates for treating epileptogenesis

Publications (1)

Publication Number	Publication Date
PL1809273T3 true PL1809273T3 (pl)	2010-09-30

Family

ID=42664717

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL05810288T PL1809273T3 (pl)	2004-09-16	2005-09-15	Zastosowanie (di)karbaminianów 2-fenylo-1,2-etanodiolu do leczenia rozwoju padaczki

Country Status (3)

Country	Link
EP (1)	EP1809273B1 (pl)
PL (1)	PL1809273T3 (pl)
SI (1)	SI1809273T1 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PL225258B1 (pl)	2013-08-09	2017-03-31	Univ Jagiellonski	Nowe pochodne N-[(fenoksy)etoksy]alkiloaminoalkanoli oraz ich zastosowanie do wytwarzania leków

2005
- 2005-09-15 EP EP05810288A patent/EP1809273B1/en not_active Expired - Lifetime
- 2005-09-15 PL PL05810288T patent/PL1809273T3/pl unknown
- 2005-09-15 SI SI200531049T patent/SI1809273T1/sl unknown

Also Published As

Publication number	Publication date
SI1809273T1 (sl)	2010-08-31
EP1809273A2 (en)	2007-07-25
EP1809273B1 (en)	2010-04-14

Similar Documents

Publication	Publication Date	Title
EP1715799A4 (en)	2010-06-02	METHOD FOR TREATING GLAUCOMA
ZA200801402B (en)	2009-10-28	Use of 2-phenyl-L, 2-ethanediol-(DI) carbamates for treating epileptogenesis and epilepsy
IL183059A0 (en)	2007-10-31	Cancer treatment method
IL182993A0 (en)	2007-09-20	Treatment of mastitis
ZA200701488B (en)	2008-08-27	Plant treatment material
EP1755394A4 (en)	2009-08-05	METHOD OF TREATING CANCER
IL178920A0 (en)	2007-03-08	Treatment for pancreatic cancer
GB0422533D0 (en)	2004-11-10	Non-aqueous treatment method
IL179323A0 (en)	2007-05-15	Cancer treatment method
GB2430002B (en)	2009-06-03	Well treatment
GB0426196D0 (en)	2004-12-29	Methods of treatment
EP1809276A4 (en)	2009-06-17	PROCESSING PROCESS
IL179359A0 (en)	2007-03-08	Cancer treatment method
EP1793813A4 (en)	2011-05-18	TREATMENT OF HYPERACTIVITY DISORDER WITH DEFICIT ATTENTION (ADHD)
GB0426141D0 (en)	2004-12-29	Treatment
GB0424085D0 (en)	2004-12-01	Well treatment
PL1809273T3 (pl)	2010-09-30	Zastosowanie (di)karbaminianów 2-fenylo-1,2-etanodiolu do leczenia rozwoju padaczki
EP1802617A4 (en)	2010-12-15	CANCER TREATMENT METHOD
GB0701549D0 (en)	2007-03-07	Skin treatment
GB0423173D0 (en)	2004-11-24	Treatment of diabetes
GB0316641D0 (en)	2003-08-20	Leather treatment
HU0400952D0 (en)	2004-10-28	Treatment of anus-cancer
GB0422012D0 (en)	2004-11-03	Methods of treatment
GB0412411D0 (en)	2004-07-07	Treatment
ZA200702195B (en)	2009-09-30	Use of 2-phenyl-1,2-ethanediol (Dl) carbamates for treating epileptogenesis and epilepsy